{"first_name":"Arthur","last_name":"Altschul Jr.","permalink":"arthur-altschul-jr","crunchbase_url":"http://www.crunchbase.com/person/arthur-altschul-jr","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Mon Jan 04 19:52:35 UTC 2010","updated_at":"Mon Jan 04 19:55:09 UTC 2010","overview":"<p>Arthur G. Altschul, Jr. is the Co-Founder of Kolltan and Chairman of Kolltan&#8217;s Board of Directors. Mr. Altschul has worked in money management, investment banking and as a member of senior management of a publicly-traded health care concern. </p>\n\n<p>He is a founder of Diaz &amp; Altschul Capital Management, LLC, a private investment advisory firm. Between 1985 and 1991, Mr. Altschul worked, variously, at Goldman, Sachs &amp; Co., The Maximus Fund, LP and Morgan Stanley &amp; Co.</p>\n\n<p>From its founding in 1992 through 1996, Mr. Altschul worked at SUGEN, Inc., a biopharmaceutical company focused on cancer drug development, which was subsequently acquired by Pharmacia &amp; Upjohn, Inc. Mr. Altschul is chairman of the board of directors of Medrium, Inc., a leader in medical transaction processing; he serves on the board of directors of General American Investors, Inc. (NYSE: GAM), a publicly-traded closed-end investment company with over $1 billion in gross assets and Medicis Pharmaceutical Corporation (NYSE: MRX), a specialty pharmaceutical company focused on the dermatology market. </p>\n\n<p>He also is a director of the Delta Opportunity Fund, Ltd., and Diversified Natural Products, Inc. Mr. Altschul is a director of The Overbrook Foundation, and is a trustee of The Neurosciences Research Foundation, and the National Public Radio Foundation. Mr. Altschul received his B.Sc. in Computer Science from Columbia University.</p>","image":{"available_sizes":[[[80,80],"assets/images/resized/0007/2021/72021v1-max-150x150.jpg"],[[80,80],"assets/images/resized/0007/2021/72021v1-max-250x250.jpg"],[[80,80],"assets/images/resized/0007/2021/72021v1-max-450x450.jpg"]],"attribution":"<p>Kolltan</p>"},"degrees":[],"relationships":[{"is_past":false,"title":"Co-Founder, Chairman of the Board","firm":{"name":"Kolltan Pharmaceuticals","permalink":"kolltan-pharmaceuticals","type_of_entity":"company","image":{"available_sizes":[[[150,44],"assets/images/resized/0006/2551/62551v1-max-150x150.jpg"],[[186,55],"assets/images/resized/0006/2551/62551v1-max-250x250.jpg"],[[186,55],"assets/images/resized/0006/2551/62551v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}